Teva Pharmaceutical Industries Ltd (TEVJF) Debt Ratio (2009 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Debt Ratio came in at 0.42 in Q2 2026, down 3.02% YoY from 0.43 in Q2 2025, and little changed on a QoQ basis from 0.42 in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Debt Ratio (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 18 years of Debt Ratio data on file, last reported at 0.42 in Q2 2026.
- Quarterly Debt Ratio fell 3.02% year-over-year to 0.42 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.42 (down 3.02% YoY) and the FY2025 annual result came in at 0.41, down 8.79% from the prior year.
- Debt Ratio held at 0.42 in Q2 2026, from 0.42 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.49 in Q1 2022 to a low of 0.41 in Q4 2025.
- A 5-year average of 0.45 and a median of 0.46 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio decreased 0.21% — and 2025, when it fell 8.79%.
- Tracing TEVJF's Debt Ratio over 5 years: stood at 0.48 in 2022, then decreased by 5.36% to 0.46 in 2023, then declined by 0.87% to 0.45 in 2024, then slipped by 8.79% to 0.41 in 2025, then increased by 0.93% to 0.42 in 2026.
- The last three Debt Ratio figures came in at 0.42 (Q2 2026), 0.42 (Q1 2026), and 0.41 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.45 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.49 |
| Dec 31, 2021 | 0.48 |
| Sep 30, 2021 | 0.50 |